Patient care outcomes in hospitalized patients with acute generalized exanthematous pustulosis: a cross-sectional database study

KB Nusbaum, TD Walker, S Himed, JC Trinidad… - American Journal of …, 2023 - Springer
Background Current understanding of the etiology, natural history, and outcomes of acute
generalized exanthematous pustulosis (AGEP) has been limited, with most available studies …

Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US

A Creadore, S Desai, A Alloo, AK Dewan… - JAMA …, 2022 - jamanetwork.com
Importance Acute generalized exanthematous pustulosis (AGEP) is a rare, severe
cutaneous adverse reaction associated with systemic complications. Currently available …

Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996 …

DT Alniemi, DA Wetter, AG Bridges… - International journal …, 2017 - Wiley Online Library
Background Acute generalized exanthematous pustulosis (AGEP) is a rare skin condition
typically caused by medications. The objective of this study was to examine the clinical …

Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management

R Parisi, H Shah, AA Navarini, B Muehleisen… - American Journal of …, 2023 - Springer
Acute generalized exanthematous pustulosis (AGEP) is a rare, acute, severe cutaneous
adverse reaction mainly attributed to drugs, although other triggers, including infections …

[HTML][HTML] Acute generalized exanthematous pustulosis: Epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center

DAQ Oh, YW Yeo, KJL Choo, SM Pang, CC Oh… - JAAD international, 2021 - Elsevier
Background Acute generalized exanthematous pustulosis (AGEP) is a rare severe
cutaneous adverse drug reaction. Although acutely patients have significant morbidity and …

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients

C Hotz, L Valeyrie‐Allanore, C Haddad… - British Journal of …, 2013 - academic.oup.com
Background Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous
adverse reaction characterized by rash with sterile pustules, high fever and elevated …

[HTML][HTML] Acute generalized exanthematous pustulosis

MJ Moore, NC Sathe, VM Ganipisetti - 2023 - europepmc.org
Objectives: Describe the epidemiology of acute generalized exanthematous pustulosis
(AGEP). Review the clinical presentation of AGEP. Identify the diagnostic findings and …

[HTML][HTML] Acute generalized exanthematous pustulosis: A retrospective study of 51 cases in Taiwan

YY Lee, WH Chung - Dermatologica Sinica, 2014 - Elsevier
Abstract Background/Objective Acute generalized exanthematous pustulosis (AGEP) is a
severe cutaneous adverse drug reaction characterized by fever and numerous sterile non …

Drug triggers and clinic of acute generalized exanthematous pustulosis (AGEP): a literature case series of 297 patients

E Vallejo-Yagüe, A Martinez-De la Torre… - Journal of Clinical …, 2022 - mdpi.com
Acute generalized exanthematous pustulosis (AGEP) is a rare skin reaction, commonly
caused by drugs. Available evidence mostly relies on small studies or case reports. We …

Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)

A Sidoroff, A Dunant, C Viboud, S Halevy… - British Journal of …, 2007 - academic.oup.com
Background Acute generalized exanthematous pustulosis (AGEP) is a disease
characterized by the rapid occurrence of many sterile, nonfollicular pustules usually arising …